TipRanks
Go Ultimate55% OFF

Trimas (MQ1) AI Stock Analysis

0 Followers
DE:MQ1

Trimas

(Frankfurt:MQ1)

Rating:―N/A
Action:N/A
Date:―

No summary available

Positive Factors
Strong Balance SheetTriMas has substantial liquidity, net cash, and no near-term debt maturities, giving it financial flexibility through operating volatility. This supports continued investment in organic growth, productivity, or disciplined acquisitions while preserving capacity for shareholder returns.
Negative Factors
Weak Cash ConversionNegative operating and free cash flow represent a material deterioration from prior positive periods and weaken confidence in reported earnings quality. Persistent cash shortfalls could constrain investment and capital returns even though the balance sheet currently provides substantial liquidity.

Trimas (MQ1) vs. iShares MSCI Germany ETF (EWG)

-10%0%10%20%30%40%50%DE:MQ1+26.86%EWG+9.86%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
EUR 1.41B
Dividend Yield
0.41%
Average Volume (3M)
―
Price to Earnings (P/E)
1.6
Beta (1Y)
0.31
Revenue Growth
-36.38%
EPS Growth
2028.60%
Country
Germany
Employees
3,700
Sector
Consumer Cyclical
Sector Strength
61
Industry
Packaging & Containers

Trimas Business Overview & Revenue Model

Company Description

TriMas Corporation (TRS) is a global industrial company focused on the engineering, manufacturing, and distribution of a diverse range of products spanning consumer, aerospace, and industrial markets. Its operations are structured into three primary...

Trimas Earnings Call Summary

Earnings Call Date:Oct 28, 2026(Q3-2026)|% Change Since:-2.27%|Next Earnings Date:Mar 03, 2027
Earnings Call SentimentPositive

The call was predominantly positive, with strong third-quarter and year-to-date revenue, operating profit, earnings, Packaging performance, cost-reduction progress, share repurchases, liquidity, and reaffirmed full-year guidance. The main challenges were the ongoing Norris Cylinder throughput and productivity issues, reduced Specialty Products margin expectations, delayed Packaging price-cost recovery, seasonal fourth-quarter softness, and the absence of a completed acquisition announcement.

Positive Updates

Strong Third-Quarter Revenue and Earnings Growth
Third-quarter net sales increased 7.7% to $178.7 million, including 7.2% organic growth supported by growth across all major end markets served by Packaging and Specialty Products. Operating profit increased 47.9% to $13.6 million, operating profit margin expanded 200 basis points to 7.6%, and adjusted earnings per share increased to $0.50 from $0.17 in the prior-year period.

Negative Updates

Specialty Products Profitability Declines
Specialty Products operating profit was $0.1 million compared with $2.4 million in the prior-year period. Profitability was affected by manufacturing inefficiencies during production ramp-up activities, including machine downtime, lower labor productivity, and throughput constraints that more than offset the benefit of higher sales volumes.

Company Guidance

TriMas reaffirmed its adjusted earnings per share outlook of $1.60-$1.70, expects Packaging and Specialty Products to collectively deliver 4%-6% year-over-year sales growth, and continues to expect operating profit margin expansion of 250 basis points for the year; Packaging’s full-year sales outlook is 4%-5% sales growth and full-year operating profit margin of nearly 14%, with fourth quarter sales expected to moderate sequentially while both sales and operating margins are expected to improve compared to the prior year period; Specialty Products is expected to deliver full-year sales growth of 7%-10% and full-year operating profit margins in the range of 4%-6%; fourth quarter sales, earnings, and earnings per share are expected to improve year-over-year, while the fourth quarter is typically our seasonally weakest period, and fourth quarter should be by far the best free cash flow generation quarter of the year; previously announced cost reduction actions totaling $10.5 million in expected 2026 savings and $16 million on an annualized basis remain on track, and Rapak contributed approximately $20 million of annual sales.

Trimas Risk Analysis

Trimas disclosed 29 risk factors in its most recent earnings report. Trimas reported the most risks in the "Finance & Corporate" category.

Higher RiskSector Avg.Lower RiskFinance & CorporateTech & InnovationLegal & RegulatoryProductionAbility to SellMacro & Political
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy

Latest Risks Added

0 New Risks

Trimas Peers Comparison

Overall Rating

UnderperformOutperform
Sector (61)

Financial Indicators

DE:MQ1 against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
SLGNSLGN72Outperform$4.39B17.2011.09%1.95%4.48%-16.03%
CCKCCK71Outperform$13.05B17.3127.10%1.12%13.75%-11.09%
MYEMYE62Neutral$1.05B24.2314.84%1.89%-12.90%27.70%
Sector *61Neutral$18.38B12.79-2.54%3.03%1.52%-15.83%
PACKPACK51Neutral$255.64M-8.40-6.65%―8.27%6.75%
SONSON45Neutral$4.83B-24.47-6.12%4.14%3.56%-11673.60%

* Consumer Cyclical Sector Average

Performance Comparison

0%50%100%DE:MQ1CCKMYESLGNSONPACKDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
DE:MQ1 and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
DE:MQ1Trimas34.406.6924.12%
CCKCrown Holdings124.7829.6731.19%
MYEMyers Industries28.5911.4867.12%
SLGNSilgan42.665.2313.98%
SONSonoco Products Company51.6312.8633.16%
PACKRanpak Holdings Corp. Class A3.36-1.58-31.98%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.